News Daily News AHA/ASA Release New Comprehensive Acute Ischemic Stroke Guideline Todd Neale January 29, 2026
News Daily News Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure Michael O'Riordan December 30, 2025
News Daily News SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide Michael O'Riordan December 18, 2025
News Daily News AHA Highlights Single-Pill Combo Therapy for Hypertension Todd Neale December 17, 2025
News Daily News Aprocitentan Effective in CKD Patients With Resistant Hypertension: PRECISION Todd Neale December 16, 2025
News Daily News Semaglutide’s CV Effects Only Partially Tied to Weight Loss: SELECT Analysis Yael L. Maxwell October 24, 2025
News Daily News Bax24: Baxdrostat Successful Again, This Time in Resistant Hypertension Todd Neale October 07, 2025
News Conference News ESC 2025 Home-Based Intervention Drops Blood Pressure in Rural South Africa Todd Neale September 04, 2025
News Conference News ESC 2025 NEWTON-CABG CardioLink-5: Evolocumab Doesn’t Prevent SVG Failure Michael O'Riordan September 04, 2025
News Conference News ESC 2025 BaxHTN: Baxdrostat Lowers BP in Uncontrolled and Resistant Hypertension Todd Neale August 31, 2025
News Daily News AI-Supported Coaching Shows Promise for Improving Glycemic Control L.A. McKeown August 25, 2025
News Daily News Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050 Todd Neale July 16, 2025
News Daily News Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC Michael O'Riordan June 25, 2025
News Daily News Weight-Loss Drug MariTide Gains Momentum in Phase II Trial Caitlin E. Cox June 25, 2025
News Conference News ESOC 2025 Simple, Phone-Based Strategy Improves BP Control in Stroke Survivors Todd Neale June 02, 2025
News Conference News European Congress on Obesity 2025 SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly Michael O'Riordan May 14, 2025